ArticleLeukemia2018

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling.

G Kerdivel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.